Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov;16(6):668-686.
doi: 10.1016/j.ajps.2020.12.003. Epub 2021 May 2.

Advances in photosensitizer-related design for photodynamic therapy

Affiliations
Review

Advances in photosensitizer-related design for photodynamic therapy

Zhaojie Zhou et al. Asian J Pharm Sci. 2021 Nov.

Abstract

Photodynamic therapy (PDT) is highly effective in treating tumors located near body surface, offering strong tumor suppression and low damage to normal tissue nearby. PDT is also effective for treating a number of other conditions. PDT not only provide a precise and selective method for the treatment of various diseases by itself, it can also be used in combination with other traditional therapies. Because PDT uses light as the unique targeting mechanism, it has simpler and more direct targeting capability than traditional therapies. The core material of a PDT system is the photosensitizer which converts light energy to therapeutic factors/substances. Different photosensitizers have their distinct characteristics, leading to different advantages and disadvantages. These could be enhanced or compensated by using proper PDT system. Therefore, the selected type of photosensitizer would heavily influence the overall design of a PDT system. In this article, we evaluated major types of inorganic and organic PDT photosensitizers, and discussed future research directions in the field.

Keywords: Combination therapy; Photodynamic therapy; Photosensitizer; Porphyrin; Tumour treatment.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

Figures

Image, graphical abstract
Graphical abstract
Fig 1
Fig. 1.
(A, B) Diagram of electron energy level change under NIR radiation. (C) O2 generation curve, (D) ESR spectra O2(DMSO), (E) OH•(water). Reproduced with permission from . Copyrights 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Fig 2
Fig. 2.
Schematic diagram of light induced nanoparticles larger than nuclear pore into nucleus. Reproduced with permission from[22]. Copyrights 2019 Elsevier Ltd.
Fig 3
Fig. 3.
The main geometric parameters and chemical composition of the system studied. Reproduced with permission from[23]. Copyrights 2020 Wiley Periodicals, Inc.
Fig 4
Fig. 4.
Schematic diagram of PDT combined with chemotherapy with photoactivation. Reproduced with permission from . Copyrights 2021 Bentham Science Publishers.
Fig 5
Fig. 5.
Schematic diagram of PDT photosensitizer system of Mn compound with photodynamic agent and pH response. Reproduced with permission from . Copyrights 2021 Informa UK Limited.
Fig 6
Fig. 6.
Characterization and preparation of four arm PEG-COOH. The structure diagram and principle of AGCN—NS modified by four arm PEG-COOH. AGCN—NS covalently binds to PEG via amide bond (blue). Reproduced with permission from . Copyrights 2020 Elsevier Inc.
Fig 7
Fig. 7.
Schematic diagram of the formation of O2 and further formation of 1O2 catalyzed by MnO2 in HA/ICG-CuS@hMnO2 under near-infrared light of 808 nm. Reproduced with permission from . Copyrights 2020 Elsevier B.V.
Fig 8
Fig. 8.
Schematic of Irpy-HA for PDT in this study. Reproduced with permission from[31]. Copyrights 2019 Elsevier Ltd.
Fig 9
Fig. 9.
Schematic of the preparation for Zn2+,K+-C3N4 nanosheets. Reproduced with permission from . Copyrights 2020 Elsevier B.V.
Fig 10
Fig. 10.
Preparation and application of LSPR and GNBP-BPNS nanocomposites reinforced PTT-PDT. Reproduced with permission from . Copyrights 2020 Acta Materialia Inc, Published by Elsevier Ltd.
Fig 11
Fig. 11.
Schematic of autoamplification PDT in NIR and mechanism of 1O2 stimulation of cleavage. Reproduced with permission from . Copyrights 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Fig 12
Fig. 12.
The flowchart of synthetic of chlorin I and chlorinⅡ, a, b, c, d, e, f are available in references. Reproduced with permission from . Copyrights 2020 Elsevier Masson SAS.
Fig 13
Fig. 13.
(A, B) Evaluation of in vitro effects for NP-sfb/ce6 in PDT. (C) K1-Tumor growth curve after the first treatment. (D) The weights of K1-tumors after the treatment. Reproduced with permission from . Copyrights 2020 Elsevier Ltd.
Fig 14
Fig. 14.
(A) Elative spectral distribution of the plate-type LEDs (a) and flexible-type LEDs (b). (B) ROS produce by PpIX under different light sources. Reproduced with permission from . Copyrights 2019 Japanese Society for Investigative Dermatology, Published by Elsevier B.V.
Fig 15
Fig. 15.
(A) Decompose H2O2 to O2 in a temperature responsive manner, and increase the O2 in tumor site, then the tumors were killed by PDT. (B) Evaluation of in vitro effects for PB@PMO-5-ALA in PDT. Reproduced with permission from . Copyrights 2020 Elsevier Inc.
Fig 16
Fig. 16.
TGF-β1 analyzed by ELISA after PDT in this study. Reproduced with permission from . Copyrights 2020 Published by Elsevier B.V.
Fig 17
Fig. 17.
(A) Schematic of the structure for PMO skeleton, the reaction pathway of benzene hydroxylation and protoporphyrin IX (PpIX) loading, and the mechanism of photoinduced biological effects. (B) Evaluation of in vitro effects for PMO-PpIX in MTT. Reproduced with permission from . Copyrights 2020 by the authors. Licensee MDPI, Basel, Switzerland.
Fig 18
Fig. 18.
Schematic for preparation of PEG-CHO-Apt-PA, and the acid response principle in TME (pH=6.5). Reproduced with permission from . Copyrights 2020 Published by Elsevier Ltd.
Fig 19
Fig. 19.
Tumor inhibition in vivo. (A, B) Temperature change of tumor site after receiving light. (C, D) Tumor volume and tumor morphology after treatment in different group. Reproduced with permission from . Copyrights 2019 Elsevier Ltd.
Fig 20
Fig. 20.
Semiquantitative data of ROS production in vivo for different materials after intravenous illumination. Reproduced with permission from . Copyrights 2020 Elsevier Ltd.
Fig 21
Fig. 21.
(A) the structure of the nano-drug delivery system. (B,C,D,E,G) In vivo efficacy of TAT+AzoNPs@ (Ce6+TPZ). (I) control group, (II) the system without light, (III) Free (Ce6+TPZ) with light, (IV) TAT+AzoNPs@ TPZ with light, (V) TAT+AzoNPs@ Ce6 with light, (VI) NNPs@(Ce6+TPZ) with light, (VII) AzoNPs@(Ce6+TPZ) with light, and (VIII) the system with light. Reproduced with permission from . Copyrights 2020 Elsevier Ltd.
Fig 22
Fig. 22.
(A) Synthesis route of new tribenzo porphyrin, the synthesis steps are shown in the original text. (B) The number of viable S.aureus after PDT using TBP. Reproduced with permission from . Copyrights 2020 Elsevier B.V.
Fig 23
Fig. 23.
Parasite load of mice infected with Amazon L. amazonensis treated with TiO2/Zn in PDT. Reproduced with permission from . Copyrights 2020 Elsevier B.V.
Fig 24
Fig. 24.
Analysis of viable bacteria count after PDT treatment. Reproduced with permission from . Copyrights 2020 Elsevier B.V.

References

    1. Lan M.H., Zhao S.J., Liu W.M., Lee C.S., Zhang W.J., Wang P.F. Photosensitizers for photodynamic therapy. Adv Healthc Mater. 2019;8 - PubMed
    1. McFarland S.A., Mandel A., Dumoulin-White R., Gasser G. Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology? Curr Opin Chem Biol. 2020;56:23–27. - PMC - PubMed
    1. Chen JM, Fan TJ, Xie ZJ, Zeng QQ, Xue P, Zheng TT, et al. Advances in nanomaterials for photodynamic therapy applications: status and challenges. Biomater 2020;237:119827. - PubMed
    1. Wu W.B., Mao D., Hu F., Xu S.D., Chen C., Zhang C.J., et al. A highly efficient and photostable photosensitizer with near - infrared aggregation - induced emission for image-guided photodynamic anticancer therapy. Adv Mater. 2017;29 - PubMed
    1. Cheng H., Zheng R.R., Fan G.L., Fan J.F., Zhao L.P., Jiang X.Y., et al. Mitochondria and plasma membrane dual-targeted chimeric peptide for single-agent synergistic photodynamic therapy. Biomater. 2019;188:1–11. - PubMed

LinkOut - more resources